{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-006426","form_type":"8-K","ticker":"MD","cik":"0000893949","company_name":"Pediatrix Medical Group, Inc.","filed_at":"2022-04-28T23:59:59+00:00","discovered_at":"2026-05-14T18:04:04.188170+00:00","generated_at":"2026-06-26T03:48:11.499524+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Mednax Q1 GAAP loss $0.25/sh includes $57M debt charge; adj EPS $0.33","bullets":["Revenue $482M (+8% YoY); same-unit revenue +1.3%, volume +3.2%.","GAAP loss from continuing ops $20.9M ($0.25/sh) vs income $5.4M ($0.06/sh) prior year.","Adjusted EPS $0.33 vs $0.24 prior year; Adjusted EBITDA $50.7M vs $45.5M.","Issued $400M 5.375% notes due 2030; redeemed $1.0B 6.25% notes due 2027, causing $57M loss.","Cash from ops used $89.9M; total debt $799M at quarter end."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-006426","json":"https://secwatch.observer/filing/0000950170-22-006426.json","markdown":"https://secwatch.observer/filing/0000950170-22-006426.md","text":"https://secwatch.observer/filing/0000950170-22-006426.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/893949/000095017022006426/0000950170-22-006426-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/893949/000095017022006426/md-20220428.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T03:48:11.499524+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}